Active, not recruitingPhase 3NCT04716231

Atacicept in Subjects With IgA Nephropathy

Studying IgA Nephropathy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Vera Therapeutics, Inc.
Principal Investigator
Zeeshan Khawaja, MD
Vice President, Clinical Development
Intervention
Atacicept(biological)
Enrollment
376 enrolled
Eligibility
18 years · All sexes
Timeline
20232028

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04716231 on ClinicalTrials.gov

Other trials for IgA Nephropathy

Additional recruiting or active studies for the same condition.

See all trials for IgA Nephropathy

← Back to all trials